Denna sida på svenska

Cecilia Linde

Adjunct professor

Visiting address : Karolinska Universitetssjukhuset, Solna, S1:02 171 76 Stockholm, Sweden
Postal address : Department of Medicine, Solna (MedS), K2, Forskargrupp J Pernow, Karolinska Universitetssjukhuset, Solna, S1:02 171 76 Stockholm, Sweden
Delivery address : Karolinska Universitetssjukhuset, Solna, S1:02 171 76 Stockholm, Sweden

Publications

Association between demographic, organizational, clinical, and socio-economic characteristics and underutilization of cardiac resynchronization therapy: results from the Swedish Heart Failure Registry
Lund Lh, Braunschweig F, Benson L, Ståhlberg M, Dahlström U, Linde C
European journal of heart failure 2017;():-

Cardiac Resynchronization Therapy Follow-up: Role of Remote Monitoring
Linde C, Braunschweig F
Heart failure clinics 2017;13(1):241-251

Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study
Savarese G, Donal E, Hage C, Oger E, Persson H, Daubert Jc, et al
International journal of cardiology 2017;226():65-70

Effects of Spinal Cord Stimulation on Cardiac Sympathetic Nerve Activity in Patients with Heart Failure
Naar J, Jaye D, Linde C, Neužil P, Doškář P, Málek F, et al
Pacing and clinical electrophysiology : PACE 2017;40(5):504-513

HFpEF and HFrEF Display Different Phenotypes as Assessed by IGF-1 and IGFBP-1
Faxén Ul, Hage C, Benson L, Zabarovskaja S, Andreasson A, Donal E, et al
Journal of cardiac failure 2017;23(4):293-303

HFpEF and HFrEF exhibit different phenotypes as assessed by leptin and adiponectin
Faxén Ul, Hage C, Andreasson A, Donal E, Daubert Jc, Linde C, et al
International journal of cardiology 2017;228():709-716

Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction
Donal E, Lund Lh, Oger E, Bosseau C, Reynaud A, Hage C, et al
European heart journal cardiovascular Imaging 2017;18(6):629-635

Inflammatory Biomarkers Predict Heart Failure Severity and Prognosis in Patients With Heart Failure With Preserved Ejection Fraction A Holistic Proteomic Approach
Hage C, Michaelsson E, Linde C, Donal E, Daubert Jc, Gan Lm, et al
CIRCULATION-CARDIOVASCULAR GENETICS 2017;10(1):-

Left Ventricular Architecture, Long-Term Reverse Remodeling, and Clinical Outcome in Mild Heart Failure With Cardiac Resynchronization: Results From the REVERSE Trial
St John Sutton M, Linde C, Gold Mr, Abraham Wt, Ghio S, Cerkvenik J, et al
JACC. Heart failure 2017;5(3):169-178

New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy
Braunschweig F, Linde C, Benson L, Ståhlberg M, Dahlström U, Lund Lh
European journal of heart failure 2017;19(3):366-376

Prediction of New-Onset and Recurrent Atrial Fibrillation by Complete Blood Count Tests: A Comprehensive Systematic Review with Meta-Analysis
Weymann A, Ali-hasan-al-saegh S, Sabashnikov A, Popov Af, Mirhosseini Sj, Liu T, et al
Medical science monitor basic research 2017;23():179-222

Predictors of short-term clinical response to cardiac resynchronization therapy
Linde C, Abraham Wt, Gold Mr, Daubert Jc, Tang Asl, Young Jb, et al
European journal of heart failure 2017;19(8):1056-1063

The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study
Bosseau C, Donal E, Lund Lh, Oger E, Hage C, Mulak G, et al
Heart and vessels 2017;32(6):735-749

[2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure]
Ponikowski P, Voors Aa, Anker Sd, Bueno H, Cleland Jg, Coats Aj, et al
Kardiologia polska 2016;74(10):1037-1147

2016 ESC Guidelines for the Diagnosis and Treatment of Acute and Chronic Heart Failure
Ponikowski P, Voors Aa, Anker Sd, Bueno H, Cleland Jg, Coats Aj, et al
Revista espanola de cardiologia (English ed.) 2016;69(12):1167-

2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC
Ponikowski P, Voors Aa, Anker Sd, Bueno H, Cleland Jg, Coats Aj, et al
European journal of heart failure 2016;18(8):891-975

Cardiac resynchronization therapy in chronic heart failure with moderately reduced left ventricular ejection fraction: Lessons from the Multicenter InSync Randomized Clinical Evaluation MIRACLE EF study
Linde C, Curtis Ab, Fonarow Gc, Lee K, Little W, Tang A, et al
International journal of cardiology 2016;202():349-55

Determining the Feasibility of Spinal Cord Neuromodulation for the Treatment of Chronic Systolic Heart Failure: The DEFEAT-HF Study
Zipes Dp, Neuzil P, Theres H, Caraway D, Mann Dl, Mannheimer C, et al
JACC. Heart failure 2016;4(2):129-36

Improvement of blood pressure control and physicians' management over time in patients with coronary artery disease
Hägglund O, Sjöqvist I, Linde C, Svensson P, Östergren J
Blood pressure 2016;25(5):286-91

Rationale and design of the PREFERS (Preserved and Reduced Ejection Fraction Epidemiological Regional Study) Stockholm heart failure study: an epidemiological regional study in Stockholm county of 2.1 million inhabitants
Linde C, Eriksson Mj, Hage C, Wallén H, Persson B, Corbascio M, et al
European journal of heart failure 2016;18(10):1287-1297

Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study
Donal E, Lund Lh, Oger E, Reynaud A, Schnell F, Persson H, et al
European heart journal cardiovascular Imaging 2016;17(1):106-13

Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes
Zabarovskaja S, Hage C, Linde C, Daubert Jc, Donal E, Gabrielsen A, et al
International journal of cardiology 2015;189():6-11

Chronic kidney disease in patients with cardiac rhythm disturbances or implantable electrical devices: clinical significance and implications for decision making-a position paper of the European Heart Rhythm Association endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society
Boriani G, Savelieva I, Dan Ga, Deharo Jc, Ferro C, Israel Cw, et al
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015;17(8):1169-96

Copeptin in patients with heart failure and preserved ejection fraction: a report from the prospective KaRen-study
Hage C, Lund Lh, Donal E, Daubert Jc, Linde C, Mellbin L
Open heart 2015;2(1):e000260-

Current use of implantable electrical devices in Sweden: data from the Swedish pacemaker and implantable cardioverter-defibrillator registry
Gadler F, Valzania C, Linde C
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015;17(1):69-77

Effects of Cardiac Resynchronization Therapy on Cardiac Remodeling and Contractile Function: Results From Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)
St John Sutton M, Cerkvenik J, Borlaug Ba, Daubert C, Gold Mr, Ghio S, et al
Journal of the American Heart Association 2015;4(9):e002054-

European cardiac resynchronization therapy survey II: rationale and design
Dickstein K, Normand C, Anker Sd, Auricchio A, Blomström Cl, Carina Bl, et al
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015;17(1):137-41

Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure
Linde C, Ståhlberg M, Benson L, Braunschweig F, Edner M, Dahlström U, et al
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015;17(3):424-31

Increase in paced heart rate reduces muscle sympathetic nerve activity in heart failure patients treated with cardiac resynchronization therapy
Ståhlberg M, Sander M, Mortensen L, Linde C, Braunschweig F
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2015;17(3):439-46

New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study
Donal E, Lund Lh, Oger E, Hage C, Persson H, Reynaud A, et al
European journal of heart failure 2015;17(7):680-8

Opportunity to increase life span in narrow QRS cardiac resynchronization therapy recipients by deactivating ventricular pacing: evidence from randomized controlled trials
Sohaib Sm, Finegold Ja, Nijjer Ss, Hossain R, Linde C, Levy Wc, et al
JACC. Heart failure 2015;3(4):327-36

Reduced appropriate implantable cardioverter-defibrillator therapy after cardiac resynchronization therapy-induced left ventricular function recovery: a meta-analysis and systematic review
Chatterjee Na, Roka A, Lubitz Sa, Gold Mr, Daubert C, Linde C, et al
European heart journal 2015;36(41):2780-9

The effect of duration of follow-up and presence of competing risk on lifespan-gain from implantable cardioverter defibrillator therapy: who benefits the most?
Raphael Ce, Finegold Ja, Barron Aj, Whinnett Zi, Mayet J, Linde C, et al
European heart journal 2015;36(26):1676-88

The effect of reverse remodeling on long-term survival in mildly symptomatic patients with heart failure receiving cardiac resynchronization therapy: results of the REVERSE study
Gold Mr, Daubert C, Abraham Wt, Ghio S, St John Sutton M, Hudnall Jh, et al
Heart rhythm 2015;12(3):524-30

2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy
Thetask Force On Cardiac Pacing And Resynchronization Therapy Of The European Society Of Cardiology (esc). Developed In Collaboration With The European Heart Rhythm Association (ehra), Brignole M, Auricchio A, Baron-esquivias G, Bordachar P, Boriani G, et al
Revista espanola de cardiologia (English ed.) 2014;67(1):58-

Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry
Lund Lh, Benson L, Ståhlberg M, Braunschweig F, Edner M, Dahlström U, et al
European journal of heart failure 2014;16(10):1073-81

Association between cardiovascular vs. non-cardiovascular co-morbidities and outcomes in heart failure with preserved ejection fraction
Lund Lh, Donal E, Oger E, Hage C, Persson H, Haugen-löfman I, et al
European journal of heart failure 2014;16(9):992-1001

Baseline characteristics of patients with heart failure and preserved ejection fraction included in the Karolinska Rennes (KaRen) study
Donal E, Lund Lh, Oger E, Hage C, Persson H, Reynaud A, et al
Archives of cardiovascular diseases 2014;107(2):112-21

New devices in heart failure: an European Heart Rhythm Association report: developed by the European Heart Rhythm Association; endorsed by the Heart Failure Association
Kuck Kh, Bordachar P, Borggrefe M, Boriani G, Burri H, Leyva F, et al
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2014;16(1):109-28

An individual patient meta-analysis of five randomized trials assessing the effects of cardiac resynchronization therapy on morbidity and mortality in patients with symptomatic heart failure
Cleland Jg, Abraham Wt, Linde C, Gold Mr, Young Jb, Daubert Jc, et al
EUROPEAN HEART JOURNAL 2013;34(46):3547-56

COST-EFFECTIVENESS ANALYSIS OF CARDIAC RESYNCHRONIZATION THERAPY IN PATIENTS WITH NYHA I AND NYHA II HEART FAILURE IN SPAIN
Almenar L, Diaz B, Quesada A, Crespo C, Marti B, Mealing S, et al
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE 2013;29(2):140-6

Haemodynamic effects of different basic heart rates in ambulatory heart failure patients treated with cardiac resynchronization therapy
Ståhlberg M, Hilpisch K, Reiters P, Linde C, Braunschweig F
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology 2013;15(8):1182-90

Impact of ejection fraction on the clinical response to cardiac resynchronization therapy in mild heart failure
Linde C, Daubert C, Abraham Wt, St John Sutton M, Ghio S, Hassager C, et al
Circulation. Heart failure 2013;6(6):1180-9

Implantable Defibrillators Improve Survival in Patients With Mildly Symptomatic Heart Failure Receiving Cardiac Resynchronization Therapy Analysis of the Long-Term Follow-Up of Remodeling in Systolic Left Ventricular Dysfunction (REVERSE)
Gold Mr, Daubert Jc, Abraham Wt, Hassager C, Dinerman Jl, Hudnall Jh, et al
CIRCULATION-ARRHYTHMIA AND ELECTROPHYSIOLOGY 2013;6(6):1163-8

Long-term impact of cardiac resynchronization therapy in mild heart failure: 5-year results from the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study
Linde C, Gold Mr, Abraham Wt, St John Sutton M, Ghio S, Cerkvenik J, et al
European heart journal 2013;34(33):2592-9

Meta-analysis of symptomatic response attributable to the pacing component of cardiac resynchronization therapy
Sohaib Sma, Chen Zb, Whinnett Zi, Bouri S, Dickstein K, Linde C, et al
EUROPEAN JOURNAL OF HEART FAILURE 2013;15(12):1419-28

Prevalence, correlates, and prognostic significance of QRS prolongation in heart failure with reduced and preserved ejection fraction
Lund Lh, Jurga J, Edner M, Benson L, Dahlström U, Linde C, et al
European heart journal 2013;34(7):529-39

A plea for the wider use of CRT-P in candidates for cardiac resynchronisation therapy
Daubert Jc, Donal E, Linde C
HEART FAILURE REVIEWS 2012;17(6):767-75

Cardiac resynchronization therapy (CRT): Clinical trials, guidelines, and target populations
Linde C, Ellenbogen K, Mcalister Fa
HEART RHYTHM 2012;9(8):S3-S13

Chronic kidney disease and cardiac remodelling in patients with mild heart failure: results from the REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE) study
Mathew J, Katz R, Sutton Ms, Dixit S, Gerstenfeld Ep, Ghio S, et al
EUROPEAN JOURNAL OF HEART FAILURE 2012;14(12):1420-8

Effect of QRS Duration and Morphology on Cardiac Resynchronization Therapy Outcomes in Mild Heart Failure Results From the Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction (REVERSE) Study
Gold Mr, Thebault C, Linde C, Abraham Wt, Gerritse B, Ghio S, et al
CIRCULATION 2012;126(7):822-9

Heart failure with a preserved ejection fraction additive value of an exercise stress echocardiography
Donal E, Thebault C, Lund Lh, Kervio G, Reynaud A, Simon T, et al
EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING 2012;13(8):656-65

Sites of left and right ventricular lead implantation and response to cardiac resynchronization therapy observations from the REVERSE trial
Reverse Study Grp, Thebault C, Donal E, Meunier C, Gervais R, Gerritse B, et al
EUROPEAN HEART JOURNAL 2012;33(21):2662-71

The European CRT Survey: 1 year (9-15 months) follow-up results
Sci Comm, Bogale N, Priori S, Cleland Jgf, Brugada J, Linde C, et al
EUROPEAN JOURNAL OF HEART FAILURE 2012;14(1):61-73

The Limit of Plausibility for Predictors of Response: Application to Biventricular Pacing
Nijjer Ss, Pabari Pa, Stegemann B, Palmieri V, Leyva F, Linde C, et al
JACC-CARDIOVASCULAR IMAGING 2012;5(10):1046-65

Women have better long-term prognosis than men after cardiac resynchronization therapy
Zabarovskaja S, Gadler F, Braunschweig F, Stahlberg M, Hornsten J, Linde C, et al
EUROPACE 2012;14(8):1148-55

Acute haemodynamic effects of increase in paced heart rate in heart failure patients recorded with an implantable haemodynamic monitor
Stahlberg M, Kessels R, Linde C, Braunschweig F
EUROPACE 2011;13(2):237-43

Cost-effectiveness of cardiac resynchronization therapy in patients with asymptomatic to mild heart failure: insights from the European cohort of the REVERSE (Resynchronization Reverses remodeling in Systolic Left Ventricular Dysfunction)
Reverse Study Grp, Linde C, Mealing S, Hawkins N, Eaton J, Brown B, et al
EUROPEAN HEART JOURNAL 2011;32(13):1631-9

Estimation of cardiac output in patients with congestive heart failure by analysis of right ventricular pressure waveforms
Karamanoglu M, Bennett T, Stahlberg M, Splett V, Kjellstrom B, Linde C, et al
BIOMEDICAL ENGINEERING ONLINE 2011;:36-

Paroxysmal Regular Supraventricular Tachycardia: The Diagnostic Accuracy of the Transesophageal Ventriculo-Atrial Interval
Braunschweig F, Christel P, Jensen-urstad M, Andersson M, Schwieler J, Tapanainen J, et al
ANNALS OF NONINVASIVE ELECTROCARDIOLOGY 2011;16(4):327-35

The European Cardiac Resynchronization Therapy Survey: comparison of outcomes between de novo cardiac resynchronization therapy implantations and upgrades
Natl Coordinators Investigators, Bogale N, Witte K, Priori S, Cleland J, Auricchio A, et al
EUROPEAN JOURNAL OF HEART FAILURE 2011;13(9):974-83

The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume
Sci Comm, Bogale N, Priori S, Gitt A, Alings M, Linde C, et al
EUROPACE 2011;13(10):1445-53

The impact of cardiac resynchronization therapy on the incidence of ventricular arrhythmias in mild heart failure
Gold Mr, Linde C, Abraham Wt, Gardiwal A, Daubert Jc
HEART RHYTHM 2011;8(5):679-84

Transient repolarization instability following the initiation of cardiac resynchronization therapy
Braunschweig F, Pfizenmayer H, Rubulis A, Schoels W, Linde C, Bergfeldt L
EUROPACE 2011;13(9):1327-34

Cardiac Resynchronization Therapy in Asymptomatic or Mildly Symptomatic Heart Failure Patients in Relation to Etiology Results From the REVERSE (REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction) Study
Reverse Study Grp, Linde C, Abraham Wt, Gold Mr, Daubert C
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2010;56(22):1826-31

Cardiac Resynchronization Therapy in Patients With New York Heart Association Class I and II Heart Failure An Approach to 2010
Linde C, Daubert C
CIRCULATION 2010;122(10):1037-43

Estimating changes in cardiac output using an implanted hemodynamic monitor in heart failure patients
Stahlberg M, Damgaard M, Ersgard D, Norsk P, Karamanoglu M, Linde C, et al
SCANDINAVIAN CARDIOVASCULAR JOURNAL 2010;44(4):201-8

[What determines successful heart transplantation care? Low volume alone does not explain the decrease in 1-year survival]
Hultman J, Tibell A, Linde C
Lakartidningen 2010;107(6):368-discussion

Cardiac output response to changes of the atrioventricular delay in different body positions and during exercise in patients receiving cardiac resynchronization therapy
Stahlberg M, Damgaard M, Norsk P, Gabrielsen A, Sahlen A, Linde C, et al
EUROPACE 2009;11(9):1160-7

Cardiac Resynchronization Induces Major Structural and Functional Reverse Remodeling in Patients With New York Heart Association Class I/II Heart Failure
Resynchronization Reverses Remodel, Sutton Msj, Ghio S, Plappert T, Tavazzi L, Scelsi L, et al
CIRCULATION 2009;120(19):1858-65

Cardiac resynchronization therapy in mild heart failure
Linde C
EUROPACE 2009;:v72-6

Changes in Right Ventricular Pressures Between Hemodialysis Sessions Recorded by an Implantable Hemodynamic Monitor
Kjellstrom B, Braunschweig F, Lofberg E, Fux T, Grandjean Pa, Linde C
AMERICAN JOURNAL OF CARDIOLOGY 2009;103(1):119-23

Continuous central haemodynamic measurements during the six-minute walk test and daily life in patients with chronic heart failure
Braunschweig F, Linde C, Adamson Pb, Magalski A, Erdmann E, Kjellstrom B, et al
EUROPEAN JOURNAL OF HEART FAILURE 2009;11(6):594-601

European cardiac resynchronization therapy survey: rationale and design
Crt Survey Scientific Committee
European journal of heart failure 2009;11(3):326-30

Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population
Cowie Mr, Marshall D, Drummond M, Ferko N, Maschio M, Ekman M, et al
EUROPACE 2009;11(6):716-26

Predisposing Factors and Consequences of Elevated Biomarker Levels in Long-Distance Runners Aged >= 55 Years
Sahlen A, Gustafsson Tp, Svensson Je, Marklund T, Winter R, Linde C, et al
AMERICAN JOURNAL OF CARDIOLOGY 2009;104(10):1434-40

Prevention of Disease Progression by Cardiac Resynchronization Therapy in Patients With Asymptomatic or Mildly Symptomatic Left Ventricular Dysfunction Insights From the European Cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) Trial
Reverse Study Grp, Daubert C, Gold Mr, Abraham Wt, Ghio S, Hassager C, et al
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2009;54(20):1837-46

Rationale and design of the Karolinska-Rennes (KaRen) prospective study of dyssynchrony in heart failure with preserved ejection fraction
Donal E, Lund Lh, Linde C, Edner M, Lafitte S, Persson H, et al
EUROPEAN JOURNAL OF HEART FAILURE 2009;11(2):198-204

The European cardiac resynchronization therapy survey
Sci Comm Natl Coordinators, Dickstein K, Bogale N, Priori S, Auricchio A, Cleland Jg, et al
EUROPEAN HEART JOURNAL 2009;30(20):2450-60

Atrial vs. dual-chamber cardiac pacing in sinus node disease: a register-based cohort study
Fored Cm, Granath F, Gadler F, Blomqvist P, Rynder J, Linde C, et al
EUROPACE 2008;10(7):825-31

Baseline characteristics of patients randomized in The Resynchronization Reverses Remodeling In Systolic Left Ventricular Dysfunction (REVERSE) study
Linde C, Gold M, Abraham Wt, Daubert Jc, Reverse Study Group
Congestive heart failure (Greenwich, Conn.) 2008;14(2):66-74

Centres of excellence: Department of Cardiology, Karolinska University Hospital, Stockholm, Sweden
Linde C, Pernow J
CIRCULATION 2008;117(18):F103-F105

Randomized Trial of Cardiac Resynchronization in Mildly Symptomatic Heart Failure Patients and in Asymptomatic Patients With Left Ventricular Dysfunction and Previous Heart Failure Symptoms
Reverse Study Grp, Linde C, Abraham Wt, Gold Mr, Sutton Msj, Ghio S, et al
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2008;52(23):1834-43

Cardiac resynchronization therapy: clinical results and evolution of candidate selection
Leclercq C, Bleeker Gb, Linde C, Donal E, Bax Jj, Schalij Mj, et al
EUROPEAN HEART JOURNAL SUPPLEMENTS 2007;9(I):I94-I106

History of electrical therapy for the heart
Sutton R, Fisher Jd, Linde C, Benditt Dg
EUROPEAN HEART JOURNAL SUPPLEMENTS 2007;9(I):I3-I10

Correlation between serial measurements of N-terminal pro brain natriuretic peptide and ambulatory cardiac filling pressures in outpatients with chronic heart failure
Braunschweig F, Fahrleitner-pammer A, Mangiavacchi M, Ghio S, Fotuhi P, Hoppe Uc, et al
EUROPEAN JOURNAL OF HEART FAILURE 2006;8(8):797-803

Dynamic changes in right ventricular pressures during haemodialysis recorded with an implantable haemodynamic monitor
Braunschweig F, Kjellstrom B, Soderhall M, Clyne N, Linde C
NEPHROLOGY DIALYSIS TRANSPLANTATION 2006;21(1):176-83

Rationale and design of a randomized controlled trial to assess the safety and efficacy of cardiac resynchronization therapy in patients with asymptomatic left ventricular dysfunction with previous symptoms or mild heart failure - the REsynchronization reVErses Remodeling in Systolic left vEntricular dysfunction (REVERSE) study
Reverse Study Grp, Linde C, Gold M, Abraham Wt, Daubert Jc
AMERICAN HEART JOURNAL 2006;151(2):288-94

Cardiac resynchronization therapy - Part 1 - Issues before device implantation
Bax Jj, Abraham T, Barold Ss, Breithardt Oa, Fung Jwh, Garrigue S, et al
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2005;46(12):2153-67

Cardiac resynchronization therapy - Part 2 - Issues during and after device
Bax Jj, Abraham T, Barold Ss, Breithardt Oa, Fung Jwh, Garrigue S, et al
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2005;46(12):2168-82

Left atrial far-field sensing leads: A potential hazard in resynchronisation therapy
Taieb Jm, Barnay C, Linde C, Mortensen P, Menardis M
EUROPACE 2005;7(6):611-6

Monitoring of physical activity and heart rate variability in patients with chronic heart failure using cardiac resynchronization devices
Insync Iii Study Invest, Braunschweig F, Mortensen Pt, Gras D, Reiser W, Lawo T, et al
AMERICAN JOURNAL OF CARDIOLOGY 2005;95(9):1104-7

Pacing-induced electrophysiological remodeling in hypertrophic obstructive cardiomyopathy - Observations on cardiac memory
Nowinski K, Wecke L, Gadler F, Linde C, Bergfeldt L
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY 2005;28(6):561-7

Temporal characteristics of cardiac memory in humans: Vectorcardiographic quantification in a model of cardiac pacing
Wecke L, Gadler F, Linde C, Lundahl G, Rosen Mr, Bergfeldt L
HEART RHYTHM 2005;2(1):28-34

Three year outcome of cardiac resynchronization therapy: A single center evaluation
Stahlberg M, Braunschweig F, Gadler F, Karlsson H, Linde C
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY 2005;28(10):1013-7

Implantable cardioverter-defibrillator treatment and resynchronisation in heart failure
Linde C
HEART 2004;90(2):231-4

Optimization of cardiac resynchronization therapy by continuous hemodynamic monitoring: A case report
Braunschweig F, Kjellstrom B, Gadler F, Linde C
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY 2004;15(1):94-6

Six years follow-up of an implanted SvO(2) sensor in the right ventricle
Kjellstrom B, Linde C, Bennetta T, Ohlsson A, Ryden L
EUROPEAN JOURNAL OF HEART FAILURE 2004;6(5):627-34

Effects of biventricular pacing on myocardial blood flow and oxygen consumption using carbon-11 acetate positron emission tomography in patients with heart failure
Braunschweig F, Sorensen J, Von Bibra H, Olsson A, Ryden L, Langstrom B, et al
AMERICAN JOURNAL OF CARDIOLOGY 2003;92(1):95-9

Long-term improvements in quality of life by biventricular pacing in patients with chronic heart failure: Results from the MUltisite STimulation in Cardiomyopathy Study (MUSTIC)
Linde C, Braunschweig F, Gadler F, Bailleul C, Daubert Jc
AMERICAN JOURNAL OF CARDIOLOGY 2003;91(9):1090-5

Ongoing right ventricular hemodynarnics in heart failure - Clinical value of measurements derived from an implantable monitoring system
Adamson Pb, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D, et al
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2003;41(4):565-71

Rapid atrial pacing does not decrease the atrial defibrillation threshold
Frykman V, Darpo B, Ayers Gm, Bergfeldt L, Linde C, Rosenqvist M
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY 2003;26(7):1461-6

Comparative effects of permanent biventricular and right-univentricular pacing in heart failure patients with chronic atrial fibrillation
Mustic Study Grp, Leclercq C, Walker S, Linde C, Clementy J, Marshall Aj, et al
EUROPEAN HEART JOURNAL 2002;23(22):1780-7

Continuous ambulatory right heart pressure measurements with an implantable hemodynamic monitor: A multicenter, 12-month follow-up study of patients with chronic heart failure
Magalski A, Adamson P, Gadler F, Boehm M, Steinhaus D, Reynolds D, et al
JOURNAL OF CARDIAC FAILURE 2002;8(2):63-70

Continuous haemodynamic monitoring during withdrawal of diuretics in patients with congestive heart failure
Braunschweig F, Linde C, Eriksson Mj, Hofman-bang C, Ryden L
EUROPEAN HEART JOURNAL 2002;23(1):59-69

Continuous hemodynamic monitoring in heart failure
Braunschweig F, Linde C
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY 2002;13(1):S68-72

Long-term benefits of biventricular pacing in congestive heart failure: Results from the MUltisite STimulation in cardiomyopathy (MUSTIC) study
Study Grp, Linde C, Leclercq C, Rex S, Garrigue S, Lavergne T, et al
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 2002;40(1):111-8

Combipolar sensing in dual chamber pacing: Is there still a need for bipolar leads in the atrium?
Linde C, Markewitz A, Strandberg H, Larsson B, Binner L, Schuller H
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY 2001;24(11):1664-71

Effects of multisite biventricular pacing in patients with heart failure and intraventricular conduction delay.
Multisite Stimulation Cardiomyopat, Cazeau S, Leclercq C, Lavergne T, Walker S, Varma C, et al
NEW ENGLAND JOURNAL OF MEDICINE 2001;344(12):873-80

[Biventricular pacing as a new therapeutic method in heart failure. An alternative for patients with intraventricular conduction disorders]
Braunschweig F, Gadler F, Linde C, Kjellström B, Rydén L
Lakartidningen 2000;97(40):4450-2

Reduction of hospital days by biventricular pacing
Braunschweig F, Linde C, Gadler F, Ryden L
EUROPEAN JOURNAL OF HEART FAILURE 2000;2(4):399-406

Placebo effect of pacemaker implantation in obstructive hypertrophic cardiomyopathy
Pic Study Grp, Linde C, Gadler F, Kappenberger L, Ryden L
AMERICAN JOURNAL OF CARDIOLOGY 1999;83(6):903-7

Rapid return of left ventricular outflow tract obstruction and symptoms following cessation of long-term atrioventricular synchronous pacing for obstructive hypertrophic cardiomyopathy
Gadler F, Linde C, Ryden L
AMERICAN JOURNAL OF CARDIOLOGY 1999;83(4):553-7

Reuse of pacemakers
Linde C
EUROPEAN HEART JOURNAL SUPPLEMENTS 1999;1(G):G8-G11

Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy - Data from 1 year of follow-up
Pic Study Grp, Gadler F, Linde C, Daubert C, Mckenna W, Meisel E, et al
EUROPEAN HEART JOURNAL 1999;20(14):1044-50

Modification of atrioventricular conduction as adjunct therapy for pacemaker-treated patients with hypertrophic obstructive cardiomyopathy
Gadler F, Linde C, Darpo B
EUROPEAN HEART JOURNAL 1998;19(1):132-8

Incidence of sudden death after radiofrequency ablation of the atrioventricular junction for atrial fibrillation
Darpo B, Walfridsson H, Aunes M, Bergfeldt L, Edvardsson N, Linde C, et al
AMERICAN JOURNAL OF CARDIOLOGY 1997;80(9):1174-7

Long-term effects of dual chamber pacing in patients with hypertrophic cardiomyopathy without outflow tract obstruction at rest
Gadler F, Linde C, Juhlindannfelt A, Ribeiro A, Ryden L
EUROPEAN HEART JOURNAL 1997;18(4):636-42

Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy
Gadler F, Linde C, Juhlindannfelt A, Ribeiro A, Ryden L
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY 1996;27(5):1219-24

[Pacemaker in hypertrophic obstructive cardiomyopathy. A new efficient treatment of heart disease]
Gadler F, Juhlin-dannfelt A, Linde C, Ribeiro A, Rydén L
Lakartidningen 1996;93(41):3566-8

RESULTS OF ATRIOVENTRICULAR SYNCHRONOUS PACING WITH OPTIMIZED DELAY IN PATIENTS WITH SEVERE CONGESTIVE-HEART-FAILURE
Linde C, Gadler F, Edner M, Nordlander R, Rosenqvist M, Ryden L
AMERICAN JOURNAL OF CARDIOLOGY 1995;75(14):919-23

Show all publications